7,711.75

-8.75

-0.11%

53,638.00

+135.00

+0.25%

28,375.00

-191.75

-0.67%

Russell 2000 Futures

2,869.70

+3.80

+0.13%

4.8940

-0.0580

-1.17%

16.61

-4.22

-20.26%

4,141.00

+68.00

+1.67%

80,669.17

+4,629.56

+6.09%

Crude Oil Dec 26

86.87

-1.25

-1.42%

US Private Equity

10,904.74

+49.51

+0.46%

NasdaqCM - Nasdaq Real Time Price USD

Filana Therapeutics, Inc. (FLNA)

0.5720 -0.0223 (-3.75%)

At close: November 4 at 4:00:01 PM EST

Loading Chart for FLNA

Chart Range Bar

Interval:

In partnership with ChartIQ

Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells

Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells

Filana Therapeutics to Participate in the 2026 Maxim Growth Summit

Filana Therapeutics to Participate in the 2026 Maxim Growth Summit

Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy

Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy

Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update

Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update

Filana Therapeutics Reports Q1 2026 Financial Results and Business Update

Filana Therapeutics Reports Q1 2026 Financial Results and Business Update

Data I/O And 2 Other Promising Penny Stocks To Watch

Data I/O And 2 Other Promising Penny Stocks To Watch

Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII

Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII

Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data

Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data

Mobilize your Website

View Site in Mobile | Classic

Share by: